Consensus SI-BONE, Inc.

Equities

SIBN

US8257041090

Market Closed - Nasdaq 04:00:00 2024-05-10 pm EDT 5-day change 1st Jan Change
15.33 USD -1.35% Intraday chart for SI-BONE, Inc. +7.96% -26.97%

Evolution of the average Target Price on SI-BONE, Inc.

Price target over the last 5 years

History of analyst recommendation changes

914f554b11666ac74298d602eec0cc7.Hko2qCVTK47dTysTzrhB3mO5JP8JIJm5J6hDj71llzI.TRtMy39-X7mqKxx6jdAOrhqAfps-Rf30TJ8a4dkgwwZuHXvKUgly7akCZg~39db4d3a94eb474a91a1ae68fb4211ef
Morgan Stanley Trims Price Target on SI-Bone to $25 From $26, Keeps Overweight Rating MT
Piper Sandler Initiates SI-Bone With Overweight Rating, Price Target is $25 MT
Morgan Stanley Raises SI-Bone Price Target to $26 From $25, Maintains Overweight Rating MT
Truist Securities Adjusts SI-Bone Price Target to $24 From $26, Maintains Buy Rating MT
Truist Securities Adjusts Price Target on SI-Bone to $26 From $25, Maintains Buy Rating MT
Truist Securities Raises SI-Bone Price Target to $25 From $22, Maintains Buy Rating MT
Cantor Fitzgerald Adjusts SI-Bone's Price Target to $25 From $30, Maintains Overweight Rating MT
Morgan Stanley Adjusts Price Target on SI-Bone to $25 From $30, Maintains Overweight Rating MT
Needham Adjusts Price Target on SI-Bone to $25 From $32, Maintains Buy Rating MT
BofA Trims Price Target on SI-Bone to $24 From $33, Keeps Buy Rating MT
Truist Securities Adjusts Price Target on SI-Bone to $33 From $28, Maintains Buy Rating MT
Needham Adjusts Price Target on SI-Bone to $32 From $27, Maintains Buy Rating MT
Morgan Stanley Adjusts Price Target on SI-Bone to $30 From $27, Maintains Overweight Rating MT
Morgan Stanley Adjusts Price Target on SI-Bone to $27 From $22, Maintains Overweight Rating MT
Cantor Fitzgerald Adjusts Price Target on SI-Bone to $30 From $24, Maintains Overweight Rating MT
Needham Adjusts Price Target on SI-Bone to $27 From $24, Maintains Buy Rating MT
Canaccord Genuity Raises Price Target on SI-Bone to $27 From $24, Maintains Buy Rating MT
Truist Securities Adjusts Price Target on SI-Bone to $26 From $21, Maintains Buy Rating MT
Needham Adjusts Price Target on SI-Bone to $24 From $20, Maintains Buy Rating MT
Morgan Stanley Adjusts Price Target on SI-Bone to $22 From $18, Maintains Overweight Rating MT
Canaccord Genuity Adjusts Price Target on SI-Bone to $24 From $21, Maintains Buy Rating MT
Cantor Fitzgerald Adjusts Price Target on SI-Bone to $24 From $22, Maintains Overweight Rating MT
Truist Securities Adjusts Price Target on SI-Bone to $21 From $17, Maintains Buy Rating MT
Morgan Stanley Adjusts Price Target on SI-Bone to $18 From $21, Maintains Overweight Rating MT
Truist Securities Adjusts Price Target on SI-Bone to $17 From $20, Maintains Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
15.33 USD
Average target price
25.56 USD
Spread / Average Target
+66.70%
High Price Target
32 USD
Spread / Highest target
+108.74%
Low Price Target
20 USD
Spread / Lowest Target
+30.46%

Consensus detail

Consensus revision (last 18 months)

Analysts covering SI-BONE, Inc.

Morgan Stanley
Piper Sandler
Truist Securities
Cantor Fitzgerald
Needham & Co.
BofA Securities
Canaccord Genuity
JMP Securities
Jefferies & Co.
Citigroup
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
  1. Stock Market
  2. Equities
  3. SIBN Stock
  4. Consensus SI-BONE, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW